Advertisement

Future Prospects in the Treatment of Portal Hypertension

  • Takashi Tajiri
  • Hiroshi YoshidaEmail author
  • Hiroshi Makino
  • Atsushi Hirakata
  • Junji Ueda
  • Hideyuki Takata
  • Yasuhiro Mamada
  • Nobuhiko Taniai
  • Eiji Uchida
Chapter

Abstract

Various complications, such as esophagogastric varices, ectopic varices, ascites, and hepatic encephalopathy, can occur in portal hypertension. Bleeding from esophagogastric or ectopic varices is the most critical complication of portal hypertension. In 1980, general rules for recording endoscopic findings of esophageal varices were initially proposed in Japan. Revised rules were proposed as “General Rules for Recording Endoscopic Findings of Esophagogastric Varices (1991)” and “General Rules for Recording Endoscopic Findings of Esophagogastric Varices (2010).” The revised rules are simpler and more straightforward than the former rules. In 2013, “General Rules for Study of Portal Hypertension” was proposed by the Japan Society for Portal Hypertension. These rules have widely been used in Japan and other countries.

Here, we review future prospects in the treatment of portal hypertension.

Keywords

Future prospects Portal hypertension 

References

  1. 1.
    The general rules for recording endoscopic findings on esophageal varices. Jpn J Surg. 1980;10(1):84–7.Google Scholar
  2. 2.
    Idezuki Y. General rules for recording endoscopic findings of esophagogastric varices (1991). Japanese Society for Portal Hypertension. World J Surg. 1995;19(3):420–2; discussion 3.CrossRefGoogle Scholar
  3. 3.
    The Japan Society for Portal Hypertension. The general rules for study of portal hypertension. Tokyo: Kanehara Syuppan Co.; 1996.Google Scholar
  4. 4.
    Tajiri T, Yoshida H, Obara K, Onji M, Kage M, Kitano S, et al. General rules for recording endoscopic findings of esophagogastric varices (2nd edition). Dig Endosc. 2010;22(1):1–9.  https://doi.org/10.1111/j.1443-1661.2009.00929.x. DEN929 [pii].CrossRefGoogle Scholar
  5. 5.
    The Japan Society for Portal Hypertension. The general rules for study of portal hypertension. 2nd ed. Tokyo: Kanehara and Co.; 2004. p. 37–50.Google Scholar
  6. 6.
    The Japan Society for Portal Hypertension. The general rules for study of portal hypertension. 62nd ed. Tokyo: Kanehara and Co.; 2013.Google Scholar
  7. 7.
    Sengstaken RW, Blakemore AH. Balloon tamponage for the control of hemorrhage from esophageal varices. Ann Surg. 1950;131(5):781–9.CrossRefGoogle Scholar
  8. 8.
    Escorsell À, Pavel O, Cárdenas A, Morillas R, Llop E, Villanueva C, et al. Esophageal balloon tamponade versus esophageal stent in controlling acute refractory variceal bleeding: a multicenter randomized, controlled trial. Hepatology. 2016;63(6):1957–67.  https://doi.org/10.1002/hep.28360.CrossRefPubMedGoogle Scholar
  9. 9.
    Abid S, Ali S, Baig MA, Waheed AA. Is it time to replace propranolol with carvedilol for portal hypertension? World J Gastrointest Endosc. 2015;7(5):532–9.  https://doi.org/10.4253/wjge.v7.i5.532.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Wang C, Han J, Xiao L, Jin CE, Li DJ, Yang Z. Efficacy of vasopressin/terlipressin and somatostatin/octreotide for the prevention of early variceal rebleeding after the initial control of bleeding: a systematic review and meta-analysis. Hepatol Int. 2015;9(1):120–9.  https://doi.org/10.1007/s12072-014-9594-9.CrossRefPubMedGoogle Scholar
  11. 11.
    Berzigotti A, Bosch J. Pharmacologic management of portal hypertension. Clin Liver Dis. 2014;18(2):303–17.  https://doi.org/10.1016/j.cld.2013.12.003.CrossRefPubMedGoogle Scholar
  12. 12.
    Hayashi H, Beppu T, Okabe H, Kuroki H, Nakagawa S, Imai K, et al. Functional assessment versus conventional volumetric assessment in the prediction of operative outcomes after major hepatectomy. Surgery. 2015;157(1):20–6.  https://doi.org/10.1016/j.surg.2014.06.013.CrossRefPubMedGoogle Scholar
  13. 13.
    Brunner F, Berzigotti A, Bosch J. Prevention and treatment of variceal haemorrhage in 2017. Liver Int. 2017;37(Suppl 1):104–15.  https://doi.org/10.1111/liv.13277.CrossRefPubMedGoogle Scholar
  14. 14.
    D’Amico G, Pietrosi G, Tarantino I, Pagliaro L. Emergency sclerotherapy versus vasoactive drugs for variceal bleeding in cirrhosis: a Cochrane meta-analysis. Gastroenterology. 2003;124(5):1277–91. S0016508503002695 [pii].CrossRefGoogle Scholar
  15. 15.
    Hassab MA. Nonshunt operations in portal hypertension without cirrhosis. Surg Gynecol Obstet. 1970;131(4):648–54.PubMedGoogle Scholar
  16. 16.
    Yamamoto J, Nagai M, Smith B, Tamaki S, Kubota T, Sasaki K, et al. Hand-assisted laparoscopic splenectomy and devascularization of the upper stomach in the management of gastric varices. World J Surg. 2006;30(8):1520–5.  https://doi.org/10.1007/s00268-005-0243-2.CrossRefPubMedGoogle Scholar
  17. 17.
    O’Leary JG, Lepe R, Davis GL. Indications for liver transplantation. Gastroenterology. 2008;134(6):1764–76.  https://doi.org/10.1053/j.gastro.2008.02.028.CrossRefPubMedGoogle Scholar
  18. 18.
    Hori T, Ogura Y, Onishi Y, Kamei H, Kurata N, Kainuma M, et al. Systemic hemodynamics in advanced cirrhosis: concerns during perioperative period of liver transplantation. World J Hepatol. 2016;8(25):1047–60.  https://doi.org/10.4254/wjh.v8.i25.1047.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Kawai N, Minamiguchi H, Sato M, Ikoma A, Sanda H, Nakata K, et al. Percutaneous transportal outflow-vessel-occluded sclerotherapy for gastric varices unmanageable by balloon-occluded retrograde transvenous obliteration. Hepatol Res. 2013;43(4):430–5.  https://doi.org/10.1111/j.1872-034X.2012.01078.x.CrossRefPubMedGoogle Scholar
  20. 20.
    Kanagawa H, Mima S, Kouyama H, Gotoh K, Uchida T, Okuda K. Treatment of gastric fundal varices by balloon-occluded retrograde transvenous obliteration. J Gastroenterol Hepatol. 1996;11(1):51–8.CrossRefGoogle Scholar
  21. 21.
    Hidaka H, Kokubu S, Saigenji K, Isobe Y, Maeda T. Restoration of thrombopoietin production after partial splenic embolization leads to resolution of thrombocytopenia in liver cirrhosis. Hepatol Res. 2002;23(4):265.CrossRefGoogle Scholar
  22. 22.
    Narahara Y, Kanazawa H, Fukuda T, Matsushita Y, Harimoto H, Kidokoro H, et al. Transjugular intrahepatic portosystemic shunt versus paracentesis plus albumin in patients with refractory ascites who have good hepatic and renal function: a prospective randomized trial. J Gastroenterol. 2011;46(1):78–85.  https://doi.org/10.1007/s00535-010-0282-9.CrossRefPubMedGoogle Scholar
  23. 23.
    Lo GH, Lai KH, Cheng JS, Chen MH, Chiang HT. A prospective, randomized trial of butyl cyanoacrylate injection versus band ligation in the management of bleeding gastric varices. Hepatology. 2001;33(5):1060–4.  https://doi.org/10.1053/jhep.2001.24116. S0270-9139(01)86668-4 [pii].CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Kind R, Guglielmi A, Rodella L, Lombardo F, Catalano F, Ruzzenente A, et al. Bucrylate treatment of bleeding gastric varices: 12 years’ experience. Endoscopy. 2000;32(7):512–9.CrossRefGoogle Scholar
  25. 25.
    Huang YH, Yeh HZ, Chen GH, Chang CS, Wu CY, Poon SK, et al. Endoscopic treatment of bleeding gastric varices by N-butyl-2-cyanoacrylate (Histoacryl) injection: long-term efficacy and safety. Gastrointest Endosc. 2000;52(2):160–7.  https://doi.org/10.1067/mge.2000.104976. S0016-5107(00)02407-X [pii].CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Akahoshi T, Hashizume M, Shimabukuro R, Tanoue K, Tomikawa M, Okita K, et al. Long-term results of endoscopic Histoacryl injection sclerotherapy for gastric variceal bleeding: a 10-year experience. Surgery. 2002;131(1 Suppl):S176–81. a119501 [pii].CrossRefGoogle Scholar
  27. 27.
    Sarin SK, Jain AK, Jain M, Gupta R. A randomized controlled trial of cyanoacrylate versus alcohol injection in patients with isolated fundic varices. Am J Gastroenterol. 2002;97(4):1010–5.  https://doi.org/10.1111/j.1572-0241.2002.05622.x.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Sarin SK, Govil A, Jain AK, Guptan RC, Issar SK, Jain M, et al. Prospective randomized trial of endoscopic sclerotherapy versus variceal band ligation for esophageal varices: influence on gastropathy, gastric varices and variceal recurrence. J Hepatol. 1997;26(4):826–32. S0168-8278(97)80248-6 [pii].CrossRefGoogle Scholar
  29. 29.
    Bhargava DK, Pokharna R. Endoscopic variceal ligation versus endoscopic variceal ligation and endoscopic sclerotherapy: a prospective randomized study. Am J Gastroenterol. 1997;92(6):950–3.PubMedGoogle Scholar
  30. 30.
    Tamori A, Enomoto M, Kawada N. Recent advances in antiviral therapy for chronic hepatitis C. Mediat Inflamm. 2016;2016:6841628.  https://doi.org/10.1155/2016/6841628.CrossRefGoogle Scholar
  31. 31.
    Koyama Y, Brenner DA. New therapies for hepatic fibrosis. Clin Res Hepatol Gastroenterol. 2015;39(Suppl 1):S75–9.  https://doi.org/10.1016/j.clinre.2015.06.011.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Li L, Duan M, Chen W, Jiang A, Li X, Yang J, et al. The spleen in liver cirrhosis: revisiting an old enemy with novel targets. J Transl Med. 2017;15(1):111.  https://doi.org/10.1186/s12967-017-1214-8.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Maruyama H, Yokosuka O. Ultrasonography for noninvasive assessment of portal hypertension. Gut Liver. 2017;11:464.  https://doi.org/10.5009/gnl16078.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  • Takashi Tajiri
    • 1
  • Hiroshi Yoshida
    • 1
    Email author
  • Hiroshi Makino
    • 2
  • Atsushi Hirakata
    • 2
  • Junji Ueda
    • 2
  • Hideyuki Takata
    • 2
  • Yasuhiro Mamada
    • 1
  • Nobuhiko Taniai
    • 3
  • Eiji Uchida
    • 1
  1. 1.Department of SurgeryNippon Medical SchoolTokyoJapan
  2. 2.Department of SurgeryNippon Medical School Tama Nagayama HospitalTokyoJapan
  3. 3.Department of SurgeryNippon Medical School Musashi Kosugi HospitalTokyoJapan

Personalised recommendations